Summary Background The World Health Organization (WHO) set a goal to eliminate
hepatitis C (HCV) infection globally by 2030, with specific targets to reduce new viral …

Nonalcoholic fatty liver disease (NAFLD) is on the rise and has become a major etiology for
chronic liver disease. It is frequently associated with obesity, insulin resistance …

Non-alcoholic fatty liver disease (NAFLD) is defined as a chronic liver disease characterized
by excessive fat accumulation in the liver without another obvious cause (no excessive …

Abstract The Malaysian Society of Gastroenterology and Hepatology saw the need for a
consensus statement on metabolic dysfunction‐associated fatty liver disease (MAFLD). The …

The impact of drug-induced liver injury (DILI) is global as it is observed in all age groups and
races and across multiple continents. It is associated with a wide range of therapeutic drugs …

The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing and lifestyle
interventions to treat this disease by addressing the underlying metabolic syndrome are …

In recent years, epidemiological studies have consistently demonstrated that the
coexistence of nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) …

Context Recently, the novel metabolic dysfunction-associated fatty liver disease (MAFLD)
definition has been introduced. Objective To assess the relevance of MAFLD for mortality …

In 2020, the term metabolic dysfunction-associated fatty liver disease (MAFLD) was
proposed, attributing the common disease we see in clinical practice, to its underlying …

Fatty liver disease (FLD) arouses increasingly more attention in research and clinical
practice, because of the increasing prevalence of the disease and the fact that nowadays it …